Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Villalonga

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Revista Clinica Espanola|June 15, 1976
[Metastatic localization in hepatoma]J Pedreira, J Vilaseca, C Villalonga, et al.
Revista Clinica Espanola|September 30, 1978
[Sepsis caused by E. coli. Bacteriological and clinico-epidemiological studies]J Vilaseca, C Villalonga, F Fernámdez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 1, 1996
[Fever of unknown origin in patients with HIV infection]M Riera, J Altés, F Homar, et al.
Revista Clinica Espanola|October 31, 1979
[Sepsis caused by Serratia marcescens. Report of 19 cases]J A Bosch, M Vilardell, J Vilaseca, et al.
Medicina Clinica|April 10, 1980
[Scleroderma and Rendu-Osler disease. A casual association? (author's transl)]J Forteza-Rey Borralleras, C Villalonga Piera, B Siquier Mascaró, et al.
AIDS (London, England)|February 1, 1991
Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literatureJ Altés, A Salas, M Riera, et al.
Clinical and Experimental Immunology|August 2, 2006
Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumoniaM Perez-Castellano, M Peñaranda, A Payeras, et al.
Antiviral Therapy|April 1, 1997
Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3A Ibáñez, J Peraire, A Arnó, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2005
Once-daily antiretroviral therapy: Spanish Consensus StatementF Pulido, E Ribera, S Moreno, et al.
Current HIV Research|June 22, 2012
Long-term benefits of nevirapine-containing regimens: multicenter study with 506 patients, followed-up a median of 9 yearsD Podzamczer, J M Tiraboschi, J Mallolas, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Revista Clinica Espanola|June 15, 1976
[Metastatic localization in hepatoma]J Pedreira, J Vilaseca, C Villalonga, et al.
Revista Clinica Espanola|September 30, 1978
[Sepsis caused by E. coli. Bacteriological and clinico-epidemiological studies]J Vilaseca, C Villalonga, F Fernámdez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 1, 1996
[Fever of unknown origin in patients with HIV infection]M Riera, J Altés, F Homar, et al.
Revista Clinica Espanola|October 31, 1979
[Sepsis caused by Serratia marcescens. Report of 19 cases]J A Bosch, M Vilardell, J Vilaseca, et al.
Medicina Clinica|April 10, 1980
[Scleroderma and Rendu-Osler disease. A casual association? (author's transl)]J Forteza-Rey Borralleras, C Villalonga Piera, B Siquier Mascaró, et al.
AIDS (London, England)|February 1, 1991
Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literatureJ Altés, A Salas, M Riera, et al.
Clinical and Experimental Immunology|August 2, 2006
Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumoniaM Perez-Castellano, M Peñaranda, A Payeras, et al.
Antiviral Therapy|April 1, 1997
Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3A Ibáñez, J Peraire, A Arnó, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2005
Once-daily antiretroviral therapy: Spanish Consensus StatementF Pulido, E Ribera, S Moreno, et al.
Current HIV Research|June 22, 2012
Long-term benefits of nevirapine-containing regimens: multicenter study with 506 patients, followed-up a median of 9 yearsD Podzamczer, J M Tiraboschi, J Mallolas, et al.
Pageof 4